Results 31 to 40 of about 162,486 (263)

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma

Frontiers in Oncology, 2023
BackgroundPembrolizumab, a PD-1 immune checkpoint inhibitor, is approved as first-line (1L) treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) as monotherapy or in combination with platinum and 5-fluorouracil ...
Christopher M. Black, Glenn J. Hanna, Liya Wang, Karthik Ramakrishnan, Daisuke Goto, Vladimir Turzhitsky, Gleicy M. Hair   +6 more
doaj   +1 more source

Kaplan-Meier Estimate on the Plane

The Annals of Statistics, 1988
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +3 more sources

Kaplan-Meier Survival Analysis: Practical Insights for Clinicians

Acta Médica Portuguesa
This article aims to provide a guide that will help healthcare professionals and clinical researchers from all fields that deal with Kaplan-Meier curves.
António Pedro Gomes, Bruna Costa, Rita Marques, Vitor Nunes, Constança Coelho   +4 more
doaj   +1 more source

Estimation of the Distribution of Duration of Breastfeeding from Cross-Sectional Data: Some Methodological Issue.

Journal of Biostatistics and Epidemiology, 2021
Background: Duration of breastfeeding is an important health indicator of mother and child. There are various indirect epidemiological methods available to estimate the duration of breastfeeding from cross sectional data.
Anup Kumar, Sachin Kumar, Jai Kishun, Uttam Singh, Pushpraj Pushpraj   +4 more
doaj   +1 more source

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin

BMC Medical Research Methodology, 2020
Background In the presence of dependent censoring even after stratification of baseline covariates, the Kaplan–Meier estimator provides an inconsistent estimate of risk.
Takuya Kawahara, Tomohiro Shinozaki, Yutaka Matsuyama   +2 more
doaj   +1 more source

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis

BMC Medical Research Methodology, 2016
Background The difference in restricted mean survival time ( rmstD t ∗ $$ rmstD\left({t}^{\ast}\right) $$ ), the area between two survival curves up to time horizon t ∗ $$ {t}^{\ast } $$ , is often used in cost-effectiveness analyses to estimate the ...
Béranger Lueza, Federico Rotolo, Julia Bonastre, Jean-Pierre Pignon, Stefan Michiels   +4 more
doaj   +1 more source

Time-to-event analysis

Perspectives in Clinical Research
Survival analysis (or time-to-event analysis) deals with data where the outcome of interest is the length of time until the occurrence of an event. This type of analysis is unique because the event may not occur in all participants (known as censoring ...
Priya Ranganathan, Vishal Deo, C. S. Pramesh   +2 more
doaj   +1 more source

Comparison of subsequent infection in methicillin-resistant Staphylococcus aureus nasal carriers between ST72 community-genotype and hospital genotypes: a retrospective cohort study

Antimicrobial Resistance and Infection Control, 2017
Background Carriage of methicillin-resistant Staphylococcus aureus (MRSA) is an important risk factor of subsequent infection. The purpose of our study was to compare the rates of subsequent infection among newly-admitted patients carrying MRSA between ...
So Yeon Park, Doo Ryeon Chung, Yu Ri Kang, So Hyun Kim, Sun Young Cho, Young Eun Ha, Cheol-In Kang, Kyong Ran Peck, Jae-Hoon Song   +8 more
doaj   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli, Seth Rotz, Masatoshi Takagi, Richa Sharma   +3 more
wiley   +1 more source

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients

Frontiers in Oncology, 2022
BackgroundStudies providing more evidence to guide adjuvant chemotherapy decisions in elderly colon cancer patients are expected. MethodsWe obtained data from the Surveillance, Epidemiology and End Results (SEER) database between 2004 and 2012.
Xin Chen, Junhao Tu, Xiaolan Xu, Wen Gu, Lei Qin, Haixin Qian, Zhenyu Jia, Chuntao Ma, Yinkai Xu   +8 more
doaj   +1 more source